Logo Image
|Articles|June 16, 2017

Covance Opens Lab for Companion Diagnostics

LabCorp announced that its Covance Drug Development business will open a companion diagnostics lab in Morrisville, North Carolina.

The facility also includes a genomics and molecular pathology lab to support clinical trials and diagnostic testing development, and a nuclear magnetic resonance (NMR) laboratory that houses an NMR spectrometer, approved by the FDA. The site also houses manufacturing facilities for diagnostics materials and testing components. 

Read the full release here.

 

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more